I. NIDA Mini-Convention at the Society For Neuroscience
II. 6th Annual Julius Axelrod Symposium
III. Travel Awards for poster presenters at the 6th Annual Julius Axelrod Symposium
IV. Rat shRNA library Resource Now Available
V. Highlighted Funding Opportunity Announcements
I. NIDA Mini-Convention at the Society For Neuroscience
National Institute on Drug Abuse Frontiers in Addiction Research Mini-Convention
Friday October 12, 2012
Sheraton New Orleans Hotel, 500 Canal Street, New Orleans, LA
Seating is limited. Please register online: https://seiservices.com/nida/frontiers2012/
The National Institute on Drug Abuse (NIDA) Mini-Convention, Frontiers in Addiction Research, will feature cutting-edge presentations and discussion of future directions in the neurobiology of drug abuse and addiction. The NIDA Mini-Convention includes four symposia, the SfN Jacob Waletzky Memorial Lecture and a poster session for early career investigators. The agenda this year includes:
8:00 – 8:15 Welcome: NIDA Director
8:15 – 9:35 Ghrelin, Leptin and Insulin Modulates Reward
9:35-10:10 Jacob P. Waletzky Memorial Lecture
10:30-12:15 Role of Phagocytes in Synaptic Plasticity & Remodeling in the Nervous System
12:15- 2:15 Early Career Investigators Poster Session
2:15-3:35 Brain Energetics and Neurotransmission: Fueling Neurons and Glia
3:50-5:25 Central Nervous System Immune Signaling and Addiction
II. 6th Annual Julius Axelrod Symposium
The National Institute on Drug Abuse (NIDA), the National Institute of Mental Health (NIMH), and the National Institute of Neurological Disorders and Stroke (NINDS) are co-sponsoring the 6th Annual Julius Axelrod Symposium, which celebrates the career of Dr. Julius Axelrod, one of the founders of modern neuropharmacology. This special event, to be held on Sunday, October 14, 2012 from 6:30pm - 9:30pm at the Sheraton New Orleans Hotel, 500 Canal St in conjunction with the annual meeting of the Society for Neuroscience (SfN), will feature a commemoration of Dr. Axelrod's achievements and a lecture by this year's Julius Axelrod Prize winner. The Julius Axelrod Prize is awarded by SfN and endowed by the Eli Lilly Foundation. A poster session and reception will immediately follow the Julius Axelrod Prize winner's lecture. For additional information and to register, visit: http://www.seiservices.com/nida/axelrod2012/.
III. Travel Awards for poster presenters at the 6th Annual Julius Axelrod Symposium
NIDA, NIMH, and NINDS are now soliciting applications for travel award poster presentations for this symposium. In the spirit of Dr. Axelrod's research legacy, the Institutes are seeking applicants from academia, pharmaceutical and biotech companies, and government agencies whose research is aimed at the discovery of novel drug targets, ligands, and/or new methods that can be applied to the development of medications for neurological and psychiatric disorders of interest to NIDA, NIMH, and NINDS. A $750 travel award will be given to each of the 24 poster presenters selected for this session. In recognition of Dr. Axelrod's support for the next generation of researchers, preference for travel awards will be given to post-doctoral fellows and NIH Early Stage Investigators [http://grants.nih.gov/grants/new_investigators/]. Abstracts accepted for the 2012 SfN Annual Meeting in New Orleans may be submitted for this satellite event. Please see the attached application form for details on how to apply. Application forms may also be accessed at the event website (http://www.seiservices.com/nida/axelrod2012/). Completed applications must be received via email (to Axelrod@seiservices.com) by Wednesday, September 19, 2012, 5:00 PM (EDT) to be considered for this event. All applicants will be notified of the status of their submission by Friday, September 28, 2012. For additional information, please contact: for NIDA [Roger Sorensen, rsorense@mail.nih.gov]; for NIMH [Susan Koester, koesters@mail.nih.gov]; or for NINDS [Alan Willard, aw135y@nih.gov].
IV. Rat shRNA library Resource Now Available
The NIH Blueprint, NCI and NHGRI are pleased to support the development of a Rat shRNA library by the Hannon Laboratory at Cold Sping Harbor Laboratory for the research community. The shRNAs are cloned into a GIPZ lentiviral vector. Glycerol stocks (LB/ Ampicillin 100ug per ml/Zeocin 25 ug per ml) are supplied either in 96well plates or in cryovials depending on the number of clones requested. The library contains 56841 unique sequences-verified hps covering 17904_gene ids.
Coverage statistics:
gene_ids counts
1603 1
3840 2
5342 3
4569 4
2077 5
443 6
17 7
8 8
3 9
1 10
1 13
The library is available upon request from Greg Hannon,Ph.D.
Email hannon@cshl.edu<mailto:hannon@cshl.edu>
Phone (516) 367-8455
fax (516) 367-8874
V. Highlighted Funding Opportunity Announcements
| Related | |||||||
| NIDA | 08/24/2012 | 10/19/2012 | 11/20/2012 | R01 | The Interplay of Substance Abuse and HIV-1 Infection on Glial Cell Function (R01) | ||
| NIDA | 08/24/2012 | 10/19/2012 | 11/20/2012 | R21 | The Interplay of Substance Abuse and HIV-1 Infection on Glial Cell Function (R21) | ||
| NIDA | 06/13/2012 | 07/09/2012 | 08/10/2013 | R01, R03, R15, R21, R21/R33, R37, U01 | Establish Sharing of Human Brain Image Data Relevant to Drug Addiction (Admin Supp) | ||
| NIDA | 06/08/2012 | 08/14/2012 | 08/22/2014 | R25 | Research Education Grants for Statistical and Computational Training in the Genetics of Addiction (R25) | ||
| NIH | 08/23/2012 | 10/01/2012 | 01/17/2015 | R21 | Tobacco Control Regulatory Research - R21 | ||
| NIH | 08/23/2012 | 10/01/2012 | 01/17/2015 | R01 | Tobacco Control Regulatory Research - R01 | ||
| NIH | 08/23/2012 | 10/01/2012 | 01/17/2015 | R03 | Tobacco Control Regulatory Research - R03 | ||
| Roadmap | 08/07/2012 | 09/10/2012 | 10/10/2012 | DP1 | 2013 NIH Director's Pioneer Award Program (DP1) | ||
| Roadmap | 08/07/2012 | 09/17/2012 | 10/18/2012 | DP2 | 2013 NIH Director's New Innovator Award Program (DP2) | ||
| Roadmap | 08/07/2012 | 10/19/2012 | 11/22/2012 | R01 | Development and Application of Systems Approaches for Analyzing the Impact of Genomic Variation on Tissue Transcriptomes (R01) | ||
| NIEHS | 08/23/2012 | 10/19/2012 | 11/20/2012 | R01 | TaRGET I: Chromatin Structure, Genomics, and Transcriptional Responses to the Environment (R01) |
----------
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov<mailto:listserv@list.nih.gov>, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309
No comments:
Post a Comment